With an impressive track-record of international audits, including by EU and US authorities, the Department of Pharmaceutical Analyses is one of the fastest-growing parts of QUINTA-ANALYTICA.

By using a broad range of instruments, augmented by continual investment in state-of-the-art technology, Quinta is able to perform almost every analytical technique used in the pharma industry.

Operating across two sites, and performing hundreds of validations in accordance with cGMP and ICH guidelines annually, the department offers services spanning from the validation of analytical methods, to broader activities including in-vitro-in-vivo correlation studies, cleaning validations, microbial tests, and elemental impurities analyses.

The highly experienced team, headed by Mr. Martin Kroliak, works with finished dosage forms as well as with pharmaceutical raw materials, APIs, and their intermediates. Combine that with all activities of the department being supervised by an independent Quality Assurance team, and you can be guaranteed excellence throughout.

Working both with methods provided by customers and those developed by our Analytical R&D teams, we offer a very flexible approach to meet your needs and be your true pharma partner.

Speak to Martin and his team today to learn more.

Additional News

  • 19 December 2023

    Happy new year 2024

    As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

  • 4 December 2023

    Our new clinical unit in Ostrava comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.

  • 3 October 2023

    Meet us at the heart of Pharma, CPHI 2023

    Quinta-Analytica is attending CPHI 2023 in Barcelona